FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118355275> ?p ?o ?g. }

• W3118355275 endingPage "165" @default.
• W3118355275 startingPage "160" @default.
• W3118355275 abstract "SARS-CoV-2 antibody development and immunity will be crucial for the further course of the pandemic. Until now, it has been assumed that patients who are infected with SARS-CoV-2 will develop antibodies as has been the case with other coronaviruses, like MERS-CoV and SARS-CoV. In the present study, we analyzed the development of antibodies in 77 patients with an oncologic diagnosis 26 days after positive RT-qPCR testing for SARS-CoV2. RT-qPCR and anti-SARS-CoV2-antibody methods from BGI (MGIEasy Magnetic Beads Virus DNA/RNA Extraction Kit) and Roche (Elecsys Anti-SARS-CoV-2 immunoassay) were used, respectively, according to the manufacturers' specifications. Surprisingly, antibody development was detected in only 6 of 77 individuals with a confirmed history of COVID-19. Despite multiple testing, the remaining patients did not show measurable antibody concentrations in subsequent tests. These results undermine the previous hypothesis that SARS-CoV2 infections are regularly associated with antibody development and cast doubt on the provided immunity to COVID-19. Understanding the adaptive and humoral response to SARS-CoV2 will play a key role in vaccine development and gaining further knowledge on the pathogenesis." @default.
• W3118355275 created "2021-01-18" @default.
• W3118355275 creator A5000710911 @default.
• W3118355275 creator A5001622763 @default.
• W3118355275 creator A5005799227 @default.
• W3118355275 creator A5008114224 @default.
• W3118355275 creator A5025032164 @default.
• W3118355275 creator A5031657789 @default.
• W3118355275 creator A5037832244 @default.
• W3118355275 creator A5040000790 @default.
• W3118355275 creator A5044220735 @default.
• W3118355275 creator A5048611593 @default.
• W3118355275 creator A5050240015 @default.
• W3118355275 creator A5053378887 @default.
• W3118355275 creator A5063590041 @default.
• W3118355275 creator A5075295074 @default.
• W3118355275 creator A5079061533 @default.
• W3118355275 creator A5083244445 @default.
• W3118355275 creator A5085688218 @default.
• W3118355275 date "2021-04-01" @default.
• W3118355275 modified "2023-10-18" @default.
• W3118355275 title "Rare SARS-CoV-2 antibody development in cancer patients" @default.
• W3118355275 cites W2004583429 @default.
• W3118355275 cites W2007539022 @default.
• W3118355275 cites W2474518709 @default.
• W3118355275 cites W2899307702 @default.
• W3118355275 cites W3006355661 @default.
• W3118355275 cites W3013985547 @default.
• W3118355275 cites W3016505858 @default.
• W3118355275 cites W3016955027 @default.
• W3118355275 cites W3021431776 @default.
• W3118355275 cites W3021590963 @default.
• W3118355275 cites W3035067555 @default.
• W3118355275 cites W4205198674 @default.
• W3118355275 doi "https://doi.org/10.1053/j.seminoncol.2020.12.003" @default.
• W3118355275 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7833493" @default.
• W3118355275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33500147" @default.
• W3118355275 hasPublicationYear "2021" @default.
• W3118355275 type Work @default.
• W3118355275 sameAs 3118355275 @default.
• W3118355275 citedByCount "5" @default.
• W3118355275 countsByYear W31183552752021 @default.
• W3118355275 countsByYear W31183552752022 @default.
• W3118355275 countsByYear W31183552752023 @default.
• W3118355275 crossrefType "journal-article" @default.
• W3118355275 hasAuthorship W3118355275A5000710911 @default.
• W3118355275 hasAuthorship W3118355275A5001622763 @default.
• W3118355275 hasAuthorship W3118355275A5005799227 @default.
• W3118355275 hasAuthorship W3118355275A5008114224 @default.
• W3118355275 hasAuthorship W3118355275A5025032164 @default.
• W3118355275 hasAuthorship W3118355275A5031657789 @default.
• W3118355275 hasAuthorship W3118355275A5037832244 @default.
• W3118355275 hasAuthorship W3118355275A5040000790 @default.
• W3118355275 hasAuthorship W3118355275A5044220735 @default.
• W3118355275 hasAuthorship W3118355275A5048611593 @default.
• W3118355275 hasAuthorship W3118355275A5050240015 @default.
• W3118355275 hasAuthorship W3118355275A5053378887 @default.
• W3118355275 hasAuthorship W3118355275A5063590041 @default.
• W3118355275 hasAuthorship W3118355275A5075295074 @default.
• W3118355275 hasAuthorship W3118355275A5079061533 @default.
• W3118355275 hasAuthorship W3118355275A5083244445 @default.
• W3118355275 hasAuthorship W3118355275A5085688218 @default.
• W3118355275 hasBestOaLocation W31183552751 @default.
• W3118355275 hasConcept C142724271 @default.
• W3118355275 hasConcept C159047783 @default.
• W3118355275 hasConcept C159654299 @default.
• W3118355275 hasConcept C203014093 @default.
• W3118355275 hasConcept C2522874641 @default.
• W3118355275 hasConcept C2776548049 @default.
• W3118355275 hasConcept C2779134260 @default.
• W3118355275 hasConcept C2779341262 @default.
• W3118355275 hasConcept C2780420688 @default.
• W3118355275 hasConcept C3007834351 @default.
• W3118355275 hasConcept C3008058167 @default.
• W3118355275 hasConcept C3018913218 @default.
• W3118355275 hasConcept C524204448 @default.
• W3118355275 hasConcept C71924100 @default.
• W3118355275 hasConcept C8891405 @default.
• W3118355275 hasConcept C89623803 @default.
• W3118355275 hasConceptScore W3118355275C142724271 @default.
• W3118355275 hasConceptScore W3118355275C159047783 @default.
• W3118355275 hasConceptScore W3118355275C159654299 @default.
• W3118355275 hasConceptScore W3118355275C203014093 @default.
• W3118355275 hasConceptScore W3118355275C2522874641 @default.
• W3118355275 hasConceptScore W3118355275C2776548049 @default.
• W3118355275 hasConceptScore W3118355275C2779134260 @default.
• W3118355275 hasConceptScore W3118355275C2779341262 @default.
• W3118355275 hasConceptScore W3118355275C2780420688 @default.
• W3118355275 hasConceptScore W3118355275C3007834351 @default.
• W3118355275 hasConceptScore W3118355275C3008058167 @default.
• W3118355275 hasConceptScore W3118355275C3018913218 @default.
• W3118355275 hasConceptScore W3118355275C524204448 @default.
• W3118355275 hasConceptScore W3118355275C71924100 @default.
• W3118355275 hasConceptScore W3118355275C8891405 @default.
• W3118355275 hasConceptScore W3118355275C89623803 @default.
• W3118355275 hasIssue "2" @default.
• W3118355275 hasLocation W31183552751 @default.
• W3118355275 hasLocation W31183552752 @default.

• next